SF1126 for Patients With Relapsed or Refractory Neuroblastoma

NCT02337309 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

4

Enrollment

OTHER

Sponsor class

Stopped Low patient accrual

Conditions

Neuroblastoma

Interventions

DRUG: SF1126

Sponsor

New Approaches to Neuroblastoma Therapy Consortium

Collaborators

[object Object]
[object Object]